Routine

Acne vulgaris (incl. acne conglobata / acne fulminans)

acne, acne vulgaris, comedonal acne, nodulocystic acne, acne fulminans, isotretinoin · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Chronic inflammatory disease of the pilosebaceous unit driven by follicular hyperkeratinisation, sebum, Cutibacterium acnes and inflammation. Ranges from comedonal to nodulocystic/scarring disease. Acne fulminans is a rare acute ulcerative/systemic variant needing urgent treatment. Scarring and psychological impact drive early effective therapy.

Red flags

  • Acne fulminans: sudden ulcerating/haemorrhagic nodules with fever, malaise, arthralgia, bone pain
  • Rapidly scarring nodulocystic disease
  • Virilisation / signs of androgen-secreting tumour
  • Isotretinoin: pregnancy, severe mood change/suicidal ideation, severe headache/visual symptoms (raised ICP with tetracyclines), deranged LFTs/lipids
  • Gram-negative folliculitis emerging on long-term antibiotics

Assessment

Differential diagnosis

  • Rosacea (no comedones, flushing, telangiectasia)
  • Perioral dermatitis
  • Folliculitis (bacterial / Malassezia / gram-negative)
  • Hidradenitis suppurativa (flexural, sinus tracts)
  • Drug-induced acneiform eruption (steroids, EGFR inhibitors, lithium, anticonvulsants)
  • Keratosis pilaris
  • Milia / closed comedones
  • PCOS-associated / hyperandrogenism

Investigations

  • Clinical diagnosis - grade severity (comedonal, mild-moderate papulopustular, severe nodulocystic) and scarring
  • No routine bloods for typical acne
  • If features of hyperandrogenism (hirsutism, irregular menses, virilisation): total/free testosterone, DHEAS, 17-OHP, LH/FSH, prolactin +/- pelvic USS
  • Before isotretinoin: LFTs, fasting lipids, pregnancy test (and pregnancy prevention programme in people who can become pregnant); repeat per protocol
  • Acne fulminans: FBC, CRP/ESR, consider imaging for bone lesions if arthralgia

Management

  • Grade severity and identify scarring/psychosocial burden - these upgrade therapy
  • Mild comedonal: topical retinoid +/- benzoyl peroxide; advise non-comedogenic skincare, avoid picking
  • Mild-moderate inflammatory: fixed topical retinoid + benzoyl peroxide (+/- topical antibiotic, never antibiotic monotherapy)
  • Moderate-severe / truncal: add oral tetracycline (doxycycline or lymecycline) for up to 3 months WITH topical retinoid + benzoyl peroxide (antibiotic stewardship)
  • Females: consider combined oral contraceptive or spironolactone as an alternative/adjunct to oral antibiotics
  • Severe nodulocystic, scarring, or treatment-failure: refer for oral isotretinoin
  • Acne fulminans / acute severe flare with systemic upset: oral corticosteroid cover then cautious low-dose isotretinoin - specialist only
  • Review at 8-12 weeks; stop antibiotics once controlled, maintain with topical retinoid +/- BPO

Drugs & doses

Adapalene 0.1% topical once daily at night (or tretinoin 0.025-0.05%); start alternate nights if irritant
Benzoyl peroxide 2.5-5% topical once-twice daily (bleaches fabrics; reduces resistance)
Fixed combination adapalene 0.1%/benzoyl peroxide 2.5% gel once daily [verify local]
Topical clindamycin 1% once-twice daily - ALWAYS combined with benzoyl peroxide, never as monotherapy
Azelaic acid 15-20% topical twice daily (option in pregnancy and for pigmentation)
Doxycycline 100 mg ORAL once daily (or lymecycline 408 mg od) for up to 12 weeks with topical therapy [verify local]
Erythromycin 500 mg ORAL twice daily if tetracycline contraindicated (pregnancy, <12 yr) [verify local]
Combined oral contraceptive (e.g. ethinylestradiol/levonorgestrel) for suitable females [verify local]
Spironolactone 50-100 mg ORAL once daily in females (not in pregnancy; monitor K+) [verify local dose]
Isotretinoin 0.3-0.5 mg/kg/day ORAL initially, titrate to 0.5-1 mg/kg/day, cumulative target ~120-150 mg/kg - specialist, pregnancy prevention programme mandatory [verify local dose]
Acne fulminans: prednisolone 0.5-1 mg/kg/day ORAL for 2-4 weeks, then introduce low-dose isotretinoin - specialist [verify local dose]

Disposition

Outpatient/GP management for most. Refer to dermatology for isotretinoin candidates (severe, scarring, refractory, marked psychological impact) and urgently for acne fulminans. Mental-health screening and support where impact is significant.

Complications & pitfalls

  • Permanent scarring (ice-pick, boxcar, rolling) and post-inflammatory hyperpigmentation
  • Significant depression, anxiety, social withdrawal
  • Antibiotic resistance from prolonged/monotherapy use
  • Isotretinoin adverse effects: teratogenicity, mucocutaneous dryness, hyperlipidaemia, hepatitis, mood change
  • Idiopathic intracranial hypertension (tetracycline + isotretinoin combination - avoid together)

Exam pearls

  • AAD 2024 acne guideline: benzoyl peroxide, topical retinoid, topical antibiotic and oral doxycycline are strongly recommended; isotretinoin strongly recommended for severe/scarring/refractory disease
  • Never use topical or systemic antibiotics as monotherapy - always pair with benzoyl peroxide to limit resistance
  • Treat early and to scarring risk, not just lesion count - scars are permanent
  • Do not combine oral tetracyclines with isotretinoin (intracranial hypertension risk)
  • Consider PCOS in women with acne plus hirsutism/irregular menses
  • Topical retinoid maintenance prevents relapse after oral therapy

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.